Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Measurement: Standard Units03:38

Measurement: Standard Units

78.5K
Every measurement provides three kinds of information: the size or magnitude of the measurement (a number), a standard of comparison for the measurement (a unit), and an indication of the uncertainty of the measurement. While the number and unit are explicitly represented when a quantity is written, the uncertainty is an aspect of the errors in the measurement results.
78.5K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

10.9K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K
Measurement: Derived Units03:02

Measurement: Derived Units

54.4K
The International System of Units or SI system, by international agreement, has fixed measurement units for seven fundamental properties: length, mass, time, temperature, electric current, amount of substance, and luminosity. These are called the SI base units.
54.4K
Data Reporting and Recording01:24

Data Reporting and Recording

5.4K
Reporting and recording are crucial in data documentation. The timely, thorough, and accurate documentation of facts is essential when recording patient data. Failure to record findings during an assessment or interpretation of a problem will result in loss of information and make the patient document unreliable. The reader is left with general impressions if the information is not specific. A recording is documenting data of the individual's health information in a traceable, secure, and...
5.4K
Motor Units00:46

Motor Units

61.8K
A motor unit consists of two main components: a single efferent motor neuron (i.e., a neuron that carries impulses away from the central nervous system) and all of the muscle fibers it innervates. The motor neuron may innervate multiple muscle fibers, which are single cells, but only one motor neuron innervates a single muscle fiber.
61.8K
Motor Units01:13

Motor Units

7.6K
The motor unit is a fundamental component of the neuromuscular system and plays a crucial role in coordinating muscle contractions. It consists of a somatic motor neuron, which connects and controls multiple skeletal muscle fibers, forming a single functional segment. The axon of the motor neuron branches out and establishes synaptic connections known as neuromuscular junctions with individual muscle fibers within the motor unit.
Motor units come in different sizes, with smaller units...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Palliative sedation with propofol for refractory agitation.

BMJ supportive & palliative care·2025
Same author

Dermatomyositis Related Paraneoplastic Encephalitis Presenting as Terminal Delirium in the Palliative Care Unit - A Case Report.

Journal of palliative care·2022
Same author

Chronic Obstructive Pulmonary Disease: Emerging Therapies That Can Also Palliate Symptoms #427.

Journal of palliative medicine·2021
Same author

Cannabinoids for the treatment of refractory neuropathic pruritus in amyotrophic lateral sclerosis: A case report.

Palliative medicine·2021
Same author

Management of Malignant Chylothorax with Subcutaneous Octreotide Treatment.

Journal of pain & palliative care pharmacotherapy·2021
Same author

Exploring the meaning of dignity at end of life for Chinese Canadians caregivers: A qualitative cross-cultural study.

Palliative medicine·2020

Related Experiment Video

Updated: Jan 22, 2026

Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria
08:22

Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria

Published on: May 16, 2025

552

Programmed Death 1 Inhibitor-Induced Hypothyroidism on the Palliative Care Unit: Case Report.

Kelvin Lou1, Shalini Nayar1

  • 1Department of Medicine, University of British Columbia, Kelowna, British Columbia, Canada.

Journal of Palliative Care
|July 10, 2019
PubMed
Summary
This summary is machine-generated.

Novel cancer therapies like PD-1 inhibitors can cause side effects. This case highlights pembrolizumab-induced hypothyroidism leading to fatigue and hypoglycemia, posing end-of-life diagnostic challenges.

Keywords:
fatiguehypothyroidmelanomapalliativepembrolizumabprogrammed death 1 (PD-1) inhibitor

More Related Videos

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
09:06

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

1.9K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.1K

Related Experiment Videos

Last Updated: Jan 22, 2026

Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria
08:22

Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria

Published on: May 16, 2025

552
Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
09:06

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

1.9K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.1K

Area of Science:

  • Oncology
  • Immunotherapy
  • Endocrinology

Background:

  • Emergence of novel immune-based cancer therapies, including programmed death 1 (PD-1) inhibitors, for curative and palliative care.
  • PD-1 inhibitors represent a significant advancement in cancer treatment.
  • Growing body of post-market data on PD-1 inhibitors is revealing a spectrum of associated side effects.

Observation:

  • Post-market surveillance of PD-1 inhibitors has identified a broad range of adverse events.
  • Some side effects are particularly relevant to symptom management and pose diagnostic difficulties in end-of-life care.
  • A specific case involving a patient treated with pembrolizumab is presented.

Findings:

  • The patient developed hypothyroidism as a direct result of pembrolizumab treatment.
  • This drug-induced hypothyroidism manifested as extreme fatigue.
  • Persistent hypoglycemia was also observed as a consequence of the treatment.

Implications:

  • Pembrolizumab-induced hypothyroidism can present significant challenges in symptom control for cancer patients.
  • Accurate diagnosis of treatment-related side effects is crucial, especially in palliative and end-of-life settings.
  • This case underscores the importance of monitoring endocrine function during PD-1 inhibitor therapy.